Developmental pharmacogenomics.

Developmental pharmacogenomics.

Item
http://www.wikidata.org/entity/Q37841723
Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patientsEvaluation of Off-label Prescribing at a Children's Rehabilitation Center.Age-related toxicity in patients with rhabdomyosarcoma: a report from the children's oncology group.Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.Pharmacogenomics and adverse drug reactions in children.Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.My child is unique; the pharmacokinetics are universal.Methods for pharmacokinetic analysis in young children.Adverse drug reactions in neonates: could we be documenting more?Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.Pharmacokinetics of levobupivacaine following infant spinal anesthesia.Pharmacogenomics in children: advantages and challenges of next generation sequencing applications.Developmental pharmacology; filling one knowledge gap in pediatric anesthesiology.Codeine in paediatrics: pharmacology, prescribing and controversies.
P2860

Developmental pharmacogenomics.

Item
http://www.wikidata.org/entity/Q37841723
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developmental pharmacogenomics.
@en
Developmental pharmacogenomics.
@nl
type
label
Developmental pharmacogenomics.
@en
Developmental pharmacogenomics.
@nl
prefLabel
Developmental pharmacogenomics.
@en
Developmental pharmacogenomics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Developmental pharmacogenomics.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1460-9592.2011.03533.X
P433
P478
P577
P698
P921